• Lineage Cell Therapeutics opens new California R&D facility and expands Israel manufacturing site

    3 monthes ago - By San Diego Biotechnology

    Last year, Roche and Genentech paid $50 million for licensing rights to Lineage Cell Therapeutics' OpRegen program, a cell therapy that looks to regenerate healthy versions of retinal pigment epithelial cells in patients' eyes. Now the...
    Read more ...